- Home
- GWAV vs NXTC Comparison
GWAV vs NXTC Comparison
Compare GWAV & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWAV
- NXTC
- Stock Information
- Founded
- GWAV 2002
- NXTC 2015
- Country
- GWAV United States
- NXTC United States
- Employees
- GWAV N/A
- NXTC N/A
- Industry
- GWAV Packaged Foods
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- GWAV Consumer Staples
- NXTC Health Care
- Exchange
- GWAV Nasdaq
- NXTC Nasdaq
- Market Cap
- GWAV 12.6M
- NXTC 13.9M
- IPO Year
- GWAV N/A
- NXTC 2019
- Fundamental
- Price
- GWAV $0.21
- NXTC $0.50
- Analyst Decision
- GWAV
- NXTC Strong Buy
- Analyst Count
- GWAV 0
- NXTC 2
- Target Price
- GWAV N/A
- NXTC $3.50
- AVG Volume (30 Days)
- GWAV 1.7M
- NXTC 147.5K
- Earning Date
- GWAV 06-13-2025
- NXTC 07-31-2025
- Dividend Yield
- GWAV N/A
- NXTC N/A
- EPS Growth
- GWAV N/A
- NXTC N/A
- EPS
- GWAV N/A
- NXTC N/A
- Revenue
- GWAV $33,315,859.00
- NXTC N/A
- Revenue This Year
- GWAV N/A
- NXTC N/A
- Revenue Next Year
- GWAV N/A
- NXTC N/A
- P/E Ratio
- GWAV N/A
- NXTC N/A
- Revenue Growth
- GWAV N/A
- NXTC N/A
- 52 Week Low
- GWAV $0.12
- NXTC $0.22
- 52 Week High
- GWAV $3.88
- NXTC $1.82
- Technical
- Relative Strength Index (RSI)
- GWAV 53.75
- NXTC 55.61
- Support Level
- GWAV $0.18
- NXTC $0.47
- Resistance Level
- GWAV $0.23
- NXTC $0.52
- Average True Range (ATR)
- GWAV 0.02
- NXTC 0.04
- MACD
- GWAV 0.00
- NXTC 0.00
- Stochastic Oscillator
- GWAV 63.33
- NXTC 61.67
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.